Drug intelligence / Profile preview

itaconate

Development stage
Preclinical
Modality
Small Molecules
Administration
Intravenous, Intraperitoneal
01

Overview

Itaconate is an endogenous metabolite and immunometabolic regulator that plays a critical role in guiding CD8+ T cell memory differentiation. Produced during immune responses, itaconate acts as an epigenetic modulator by directly binding to and inhibiting the lysine demethylase 5B (KDM5B). It functions as a competitive antagonist of alpha-ketoglutarate (α-KG), thereby preventing KDM5B-dependent demethylation of H3K4me3 and increasing chromatin accessibility at genes essential for memory T cell (TM) differentiation. Beyond its epigenetic effects, itaconate drives metabolic reprogramming by redirecting glucose flux from glycolysis to the pentose phosphate pathway (PPP), which sustains high levels of NADPH and glutathione to alleviate oxidative stress. This dual mechanism enhances the stem-like phenotype and persistence of T cells, making itaconate a potential therapeutic agent for improving the efficacy of CAR T cell therapies in treating viral infections and cancer.

Other names
itaconic acid2-methylidenebutanedioic acid
02

Targets

TET2 (Methylcytosine dioxygenase TET2)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)JAK1 (Janus kinase 1)GSDMD (Gasdermin D)SYK (Spleen Tyrosine Kinase)RIPK3STING (Stimulator of interferon genes protein)KEAP1 (Kelch-like ECH-associated protein 1)

Beyond the preview

Go deeper on itaconate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on itaconate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call